The following table presents selected financial data for each of the last five fiscal years. This selected financial data should be read in conjunction with the Consolidated Financial Statements and related notes beginning on page F-1 of this Annual Report on Form 10-K. Dollar amounts are presented in thousands, except for per share information:
Page 33
2018 (a)
2017 (b)
2016 (c)
2015 (d)
2014 (e)
Results of Operations:
Revenues
$
14,984,646
$
10,022,788
$
10,964,157
$
12,114,832
$
12,695,157
Net earnings attributable to Jacobs
$
163,431
$
293,727
$
210,463
$
302,971
$
328,108
Financial Position:
Current ratio
1.45 to 1
1.56 to 1
1.61 to 1
1.58 to 1
1.58 to 1
Working capital
$
1,410,891
$
1,069,953
$
1,081,784
$
1,141,512
$
1,372,332
Current assets
$
4,556,584
$
2,996,180
$
2,864,470
$
3,122,678
$
3,722,178
Total assets
$
12,645,795
$
7,380,859
$
7,360,022
$
7,785,926
$
8,453,659
Cash
$
793,358
$
774,151
$
655,716
$
460,859
$
732,647
Long-term debt
$
2,146,877
$
235,000
$
385,330
$
584,434
$
764,075
Total Jacobs stockholders’ equity
$
5,854,345
$
4,428,352
$
4,265,276
$
4,291,745
$
4,469,255
Return on average equity
3.18
%
6.76
%
4.92
%
6.92
%
7.56
%
Backlog:
$
27,298,614
$
19,788,613
$
18,760,529
$
18,806,570
$
18,380,034
Per Share Information:
Basic earnings per share
$
1.18
$
2.43
$
1.75
$
2.42
$
2.51
Diluted earnings per share
$
1.17
$
2.42
$
1.73
$
2.40
$
2.48
Stockholders’ equity
$
42.21
$
36.78
$
35.26
$
34.85
$
33.92
Average Number of Shares of Common Stock and Common Stock Equivalents Outstanding (Diluted)
138,712
120,147
121,483
126,110
132,371
Common Shares Outstanding At Year End
142,218
120,386
120,951
123,153
131,753
Cash Dividends Declared Per Common Share
$
0.60
$
0.60
$
—
$
—
$
—
(a)
Includes costs of $140.1 million, or $1.01 per diluted share, related to the Company's restructuring and other initiatives during fiscal 2018, which includes $21.0 million in loss related to the sale of the Company's investment in Guimar Engenharia Ltda. Also included in fiscal 2018 are after-tax charges of $60.7 million, or $0.44 per diluted share, in professional fees and related costs associated with the CH2M acquisition and pending ECR sale and $259.2 million, or $1.86 per diluted share, in benefits related to tax reform.
(b)
Includes costs of $87.9 million, or $0.73 per diluted share, related to the Company's restructuring and other initiatives during fiscal 2017. Also included in the fourth quarter of fiscal 2017 are after-tax charges of $10.6 million, or $0.09 per diluted share, respectively, in professional fees and related costs associated with the CH2M acquisition.
(c)
Includes costs of $135.6 million, or $1.12 per diluted share, related to the Company's restructuring initiatives during fiscal 2016. Also included in the fourth quarter of fiscal 2016 are (i) a loss on sale of our French subsidiary of $17.1 million or $0.14 per diluted share; and (ii) a non-cash write-off on an equity investment of $10.4 million or $0.09 per diluted share.
(d)
Includes costs of $107.9 million, or $0.86 per diluted share, related to the Company's restructuring initiatives during fiscal 2015.
(e)
Includes costs of $109.2 million, or $0.82 per diluted share, related to the Company's restructuring initiatives during fiscal 2014.
filings.tools